Free insulin-like growth factor-I and breast cancer risk

International Journal of Cancer

Volumn 91, Issue 5, 2001, Pages 736-739

  Li, Benjamin D L ^a,b   Javad Khosravi, M ^a   Berkel, Hans J ^a   Diamandi, Anastasia ^a   Dayton, Mark A ^a   Smith, Mylinh ^a   Yu, Herbert ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Diagnostic Systems Laboratories Canada Inc   (Canada)

Author keywords

Breast cancer; Insulin like growth factor binding proteins; Insulin like growth factors

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MITOGENESIS; MOLECULAR INTERACTION; PREMENOPAUSE; PRIORITY JOURNAL;

EID: 0035283894     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1111>3.0.co;2-%23     Document Type: Article

References (36)

1. Insulin-like growth factors and cancer
2. Insulin-like growth factors and cancer
3. Endocrine effects of IGF-I on normal and transformed breast epithelial cells: Potential relevance to strategies for breast cancer treatment and prevention
4. Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs
5. Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells
6. Expression of the insulin-like growth factor I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells
7. Insulin-like growth factor-binding protein 3 is decreased in early-stage operable premenopausal breast cancer
8. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
9. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast
10. Molecular and cellular aspects of the insulin-like growth factor I receptor
11. Structure and function of the insulin-like growth factor I receptor
12. Insulin-like growth factor-binding protein (IGFBPs) and their regulatory dynamics
13. Insulin-like growth factor binding proteins and their role in controlling IGF actions
14. Insulin-like growth factors and their binding proteins: Biological antions
15. Growth, differentiation, and survival: Multiple physiological functions for insulin-like growth factors
16. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency
17. Serum insulin-like growth factors and insulin-like growth factor-binding proteins: Clinical implications
18. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
19. Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins-1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty
20. Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation
21. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
22. Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control study
23. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
24. Immunoassay of insulin-like growth factor binding protein-3 (IGFBP-3): New meanings to quantifying IGFBP-3 proteolysis
25. Heparin, heparin sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes
26. Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin
27. Transport of IGF-I across epithelial cell monolayers
28. Transport of circulating IGF-I and LR31IGF-I from blood to extracellular wound fluid sites in rats
29. High ratios of free to total insulin-like growth factor-I in early infancy
30. Increase in free insulin-like growth factor-I levels in precocious and normal puberty
31. Serum free insulin-like growth factor I (IGF-I), total IGF-I, ad IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency
32. Evaluation of free insulin-like growth factor-I measurement on the diagnosis and follow-up treatment of growth hormone-deficient adult patients
33. Serum concentrations of insulin, insulin-like growth factor-I and insulin-like growth factor binding proteins are different between white and African American girls
34. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome
35. Dietary supplements of dehydroepiandrosterone in relation to breast cancer risk